First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia-Reference-Cited by-同舟云学术

First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia

Published:2012-03-30 Issue:10 Volume:26 Page:2254-2259
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Rea D,Etienne G,Nicolini F,Cony-Makhoul P,Johnson-Ansah H,Legros L,Huguet F,Tulliez M,Gardembas M,Bouabdallah K,Rousselot P,Cayuela J-M,Guilhot F,Mahon F-X

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201292.pdf

Reference22 articles.

1. Sokal JE, Gomez GA, Baccarani M, Tura S, Clarkson BD, Cervantes F et al. Prognostic significance of additional chromosomal abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood 1988; 72: 294–298.

2. Redaelli A, Bell C, Casagrande J, Stephens J, Botteman M, Laskin B et al. Clinical and epidemiologic burden of chronic myelogenous leukemia. Expert Rev Anticancer Ther 2004; 4: 85–96.

3. Faderl S, Talpaz M, Estrov Z, O’Brien S, Kurzrock R, Kantarjian HM . The biology of chronic myeloid leukemia. New Engl J Med 1999; 341: 164–172.

4. Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F et al. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood 2002; 99: 1928–1937.

5. Kantarjian H, Talpaz M, O’Brien S, Giles F, Faderl S, Vertovsek S et al. Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia-comparison with historic experience. Cancer 2005; 103: 2099–2108.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contemporary Role of Hematopoietic Stem Cell Transplantation in the Management of Chronic Myeloid Leukemia: Is It the Same in All Settings?;Cancers;2024-02-12

2. Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT);Transplantation and Cellular Therapy;2024-01

3. Accelerated-phase CML: de novo and transformed;Hematology;2023-12-08

4. First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia;Leukemia Research;2023-07

5. Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights;Cells;2023-06-23